Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

326 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Complement activation and increased anaphylatoxin receptor expression are associated with cortical grey matter lesions and the compartmentalised inflammatory response of multiple sclerosis.
Evans R, Watkins LM, Hawkins K, Santiago G, Demetriou C, Naughton M, Dittmer M, Rees MI, Fitzgerald D, Morgan BP, Neal JW, Howell OW. Evans R, et al. Among authors: neal jw. Front Cell Neurosci. 2023 Mar 22;17:1094106. doi: 10.3389/fncel.2023.1094106. eCollection 2023. Front Cell Neurosci. 2023. PMID: 37032838 Free PMC article.
HER2-Mutant Advanced and/or Metastatic Non-Small-Cell Lung Cancer: A US Electronic Health Records Database Analysis of Clinical Characteristics, Treatment Practice Patterns, and Outcomes.
Waliany S, Neal JW, Engel-Nitz N, Lam C, Lin F, Park L, Le L, Nagasaka M. Waliany S, et al. Among authors: neal jw. Clin Lung Cancer. 2024 Jan 18:S1525-7304(24)00004-4. doi: 10.1016/j.cllc.2024.01.002. Online ahead of print. Clin Lung Cancer. 2024. PMID: 38403548 Free article.
THE IMPACT OF ROUTINE CARDIAC TROPONIN I-BASED CARDIOTOXICITY SCREENING ON CLINICAL OUTCOMES IN PATIENTS ON CANCER IMMUNOTHERAPY.
Ivanovic M, Chan A, Cheng E, Xu S, Lee C, You J, Franquiz M, Fazal M, Batchelder R, Wu SM, Reddy SA, Katsumoto T, Ramchandran K, Colevas AD, Khan SA, Fan AC, Cheng P, Wakelee H, Witteles R, Neal JW, Waliany S, Zhu H. Ivanovic M, et al. Among authors: neal jw. medRxiv [Preprint]. 2024 Jan 24:2024.01.22.24301442. doi: 10.1101/2024.01.22.24301442. medRxiv. 2024. PMID: 38343840 Free PMC article. Preprint.
Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study.
Nassar AH, Kim SY, Aredo JV, Feng J, Shepherd F, Xu C, Kaldas D, Gray JE, Dilling TJ, Neal JW, Wakelee HA, Liu Y, Lin SH, Abuali T, Amini A, Nie Y, Patil T, Lobachov A, Bar J, Fitzgerald B, Fujiwara Y, Marron TU, Thummalapalli R, Yu H, Owen DH, Sharp J, Farid S, Rocha P, Arriola E, D'Aiello A, Cheng H, Whitaker R, Parikh K, Ashara Y, Chen L, Sankar K, Harris JP, Nagasaka M, Ayanambakkam A, Velazquez AI, Ragavan M, Lin JJ, Piotrowska Z, Wilgucki M, Reuss J, Luders H, Grohe C, Baena Espinar J, Feiner E, Punekar SR, Gupta S, Leal T, Kwiatkowski DJ, Mak RH, Adib E, Naqash AR, Goldberg SB. Nassar AH, et al. Among authors: neal jw. J Thorac Oncol. 2024 Jan 24:S1556-0864(24)00032-7. doi: 10.1016/j.jtho.2024.01.012. Online ahead of print. J Thorac Oncol. 2024. PMID: 38278303
Efficacy of Mobocertinib and Amivantamab in Patients With Advanced Non-Small Cell Lung Cancer With EGFR Exon 20 Insertions Previously Treated With Platinum-Based Chemotherapy: An Indirect Treatment Comparison.
Ou SI, Prawitz T, Lin HM, Hong JL, Tan M, Proskorovsky I, Hernandez L, Jin S, Zhang P, Lin J, Patel J, Nguyen D, Neal JW. Ou SI, et al. Among authors: neal jw. Clin Lung Cancer. 2023 Dec 4:S1525-7304(23)00254-1. doi: 10.1016/j.cllc.2023.11.011. Online ahead of print. Clin Lung Cancer. 2023. PMID: 38114357
326 results